57-Fernando DJS, Sirribaddana SH, De Silva Dr.Perere SD, The prevelance of obesity and other coronary risk factors  in suburban Srilankan community. Asia pac J Clin Nuk. 1995 ; 1:1-4

58-Zaman MM, Rauf MA. Prevalence of hypertension in a Bungladesh adult population. J Hum Hypertense, 1999;13:547-9

59-International diabetes fedration, Diabetes atlas 2000, Brussels:IDF:2000

60-King H, Aubert RF, Herman WH, Global burden of diabetes, 1995-2025, prevalence, numerical estimates and projections. Diabetes care 1998, 21:1414-31

61-Abu Saeed M , Ali L, Hussain MZ, Rumi MA, Banu A etal,Effects of social economical conditions in prevalence of diabetes between rural and urban populations in Bungaladesh, Diabetes care 1997;20:551-5

62-Diabetes association of Srilanka, 1999 problem causes report of Srilanka. (Questionaire performa of international diabetes fedration south east asian region of the mid term meeting, 26th March 1999)

63-Singh DL , Bhattaria MD, High prevalence of diabetes and impared fasting glycemia in Urban Nepal. Diabetes Med 2003; 20:170-1

64-International diabetes fedration 2005

65-WHO expert consultation, Apropriate body mass index for asian population and its implication for policy and interventional strategies.Lancet 2004; 363(9403):157-63

66-Mekeigue PM etal, relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south asians. Lancet 1991;338:842-847

67-Potts J, Simmon D, Sex and ethics groups differences in fat distribution in group UK, south Asians and Europids. J Clin Epidemiol 1994;47 837-841

68-Yajnik LS, The insulin resistance epidemic in Indea, Fetal originlater lifer style, Nutr Rev 2001;59:1-9

69-Nishter S, Anthony S, Peter J, Charles N,etal, Waist HP ratio and low HDL predict the risk of CVD in Pakistan curr Med Re Opinion 20(1): 55-62;2004

70-Reddy KS, Shah P, Shirivastav U, Prabahakar D, etal. Coronary heart disease risk factors in an industrial population of North Indea. Can J Cardiol 1997;(13 suppl B) 26

71-Mendis S, Comparitive study of middle aged men in both rural and urban areas in Srilanka. Proc Ksm, 1996:18:64-94

72-Mendis S, Ekanayanke EM, Prevalence of coronary heart disease and cardiovascular risk factors in middle aged males in a defined population of central Srilanka, Int J Cardiol 1194; 46:135-42.

73-World Health Organization, Tobacco or health ? First global status report geneva, Switzerland: WHO;1996.

74-Zaman MM, Yoshiike N, Rouf MA, Syed MH, Khan MR, haques S, etal, Cardiovascular risk factors: Distribution & Prevention in a rural population of Bangaladesh, J Cardiovasc Risk, 2001;8:103-8.

75 Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308:367-73.

76 Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 1995; 91:2274-82.

77 Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New England Journal of Medicine. 1995; 333:1301-7.

78- No authors listed. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: West of Scotland Coronary Prevention Study. J Am Coll Cardiol. 1999; 33:909-15.

79- National Service Framework for Coronary Hearth Disease. Modern Standards and Service Models. March 2000.

80- Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989; 79:8-15.

81- Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986; 256:2835-2838.

82- Berge KG, Cannel PL, Hainline A. High-density lipoprotein cholesterol and prognosis after myocardial infarction. Circulation. 1982; 66:1176-1178.

83- Wannamethee SG, Shaper AG, Ebrahim S. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle aged British men. Stroke. 2000; 31:1882-8.

84-.Marson DJ, Ridker PM, Pearson TA, Grundy SM.  Dyslipidemia, other risk factors, the prevention of coronry heart disease.  In Fuster V, Alexander RW, O’Rourke RA Eds. Hurst’s The Heart 10 Ed.  International ed. USA, McGraw Hill Co, 2001 : 1132

85-.Tauheed S, Shoaib S, MN Haque.  Plasma fibrinogen –a coronary risk factor. Jcoll Physicians Surge Pak 1999; 2; 91–93

86-.Tauheed S, Shoaib S, Kamal A.  Haematocrit value in ischaemic heart disease. J Pak Med Assoc 1993; 43 : 34-5.

87-.CuiY, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachori PS, etal. Non-high density lipoprolin cholesterol as a predictor of cardiovascular disease mortality.  Arch Intern Med.  2001; 161:1413-9.

88-.Ballantyne CM, Andrews TC, Hsia JA, Kramer JH,  Shear C Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effects of 5 hydroxymethyl glulamyl coenzyme A reductase inhibitors on non-high density lipoprotein cholesterol. Am J Cardiol 2001; 88:265-9.

<< Previous    1...   17  18  [19]  20  21    Next >>